Cargando…

The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis

Population-based screening for colorectal cancer is an effective and cost-effective way of reducing colorectal cancer incidence and mortality. Many genetic and phenotypic risk factors for colorectal cancer have been identified, leading to development of colorectal cancer risk scores with varying dis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thomas, Chloe, Mandrik, Olena, Saunders, Catherine L., Thompson, Deborah, Whyte, Sophie, Griffin, Simon, Usher-Smith, Juliet A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611464/ https://www.ncbi.nlm.nih.gov/pubmed/34039685 http://dx.doi.org/10.1158/1940-6207.CAPR-20-0620

Ejemplares similares

Should colorectal cancer screening start at different ages for men and women? Cost‐effectiveness analysis for a resource‐constrained service
por: Thomas, Chloe, et al.
Publicado: (2021)

Implementation of risk stratification within bowel cancer screening: a community jury study exploring public acceptability and communication needs
por: Taylor, Lily C., et al.
Publicado: (2023)

The response to receiving phenotypic and genetic coronary heart disease risk scores and lifestyle advice – a qualitative study
por: Shefer, Guy, et al.
Publicado: (2016)

A community jury study exploring the public acceptability of using risk stratification to determine eligibility for cancer screening
por: Dennison, Rebecca A., et al.
Publicado: (2022)

Acceptability and potential impact on uptake of using different risk stratification approaches to determine eligibility for screening: A population‐based survey
por: Usher‐Smith, Juliet A., et al.
Publicado: (2020)

Risk prediction models for colorectal cancer in people with symptoms: a systematic review
por: Williams, Tom G. S., et al.
Publicado: (2016)

Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

Cardiovascular Risk Stratification: From Phenotype to Genotype?
por: Bittencourt, Marcio Sommer
Publicado: (2018)

Correction to: Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth
por: McAnally, Heath, et al.
Publicado: (2020)

External validation of risk prediction models for incident colorectal cancer using UK Biobank
por: Usher-Smith, J A, et al.
Publicado: (2018)

The spectrum effect in tests for risk prediction, screening, and diagnosis
por: Usher-Smith, Juliet A, et al.
Publicado: (2016)

Correction: External validation of risk prediction models for incident colorectal cancer using UK Biobank
por: Usher-Smith, J. A., et al.
Publicado: (2020)

The impact of information about different absolute benefits and harms on intention to participate in colorectal cancer screening: A think-aloud study and online randomised experiment
por: Usher-Smith, Juliet A., et al.
Publicado: (2021)

Mapping the Economic Costs and Benefits of Conservation
por: Naidoo, Robin, et al.
Publicado: (2006)

Acceptability of risk stratification within population‐based cancer screening from the perspective of the general public: A mixed‐methods systematic review
por: Taylor, Lily C., et al.
Publicado: (2023)

Response to Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: McAnally, Heath B., et al.
Publicado: (2021)

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial
por: Siika, Abraham, et al.
Publicado: (2018)

Reply: cost-effectiveness of population-based screening for colorectal cancer
por: Sharp, L, et al.
Publicado: (2013)

Acceptability of risk stratification within population-based cancer screening from the perspective of healthcare professionals: A mixed methods systematic review and recommendations to support implementation
por: Taylor, Lily C., et al.
Publicado: (2023)

What are the cost-savings and health benefits of improving detection and management for six high cardiovascular risk conditions in England? An economic evaluation
por: Thomas, Chloe, et al.
Publicado: (2020)

Risk prediction tools for cancer in primary care
por: Usher-Smith, Juliet, et al.
Publicado: (2015)

Venous Thromboembolism Risk Stratification and Chemoprophylaxis: A Meta-Analysis Finds No Benefit, More Risk
por: Swanson, Eric
Publicado: (2017)

Editorial: Novel phenotyping and risk stratification strategies for heart failure
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2023)

Risk–benefit and cost–benefit ratio in headache treatment
por: Pini, L. A., et al.
Publicado: (2005)

Robust Machine Learning for Colorectal Cancer Risk Prediction and Stratification
por: Nartowt, Bradley J., et al.
Publicado: (2020)

Effectiveness and cost-effectiveness of an awareness campaign for colorectal cancer: a mathematical modeling study
por: Whyte, Sophie, et al.
Publicado: (2014)

Letter to the Editor: Comment on “Gabapentinoid Benefit and Risk Stratification: Mechanisms Over Myth”
por: Peckham, Alyssa M., et al.
Publicado: (2021)

Economic Benefits and Costs Associated With Target Vaccinations
por: Armstrong, Edward P.
Publicado: (2007)

Risk Prediction Models for Kidney Cancer: A Systematic Review
por: Harrison, Hannah, et al.
Publicado: (2021)

The "influenza vaccine" – benefit, risk, costs
por: Allwinn, R., et al.
Publicado: (2002)

The current state of genetic risk models for the development of kidney cancer: a review and validation
por: Harrison, Hannah, et al.
Publicado: (2022)

COST–RISK–BENEFIT ANALYSIS IN DIAGNOSTIC RADIOLOGY: A THEORETICAL AND ECONOMIC BASIS FOR RADIATION PROTECTION OF THE PATIENT
por: Moores, B. Michael
Publicado: (2016)

Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan
por: Mandrik, Olena, et al.
Publicado: (2015)

Visualising health risks with medical imaging for changing recipients’ health behaviours and risk factors: Systematic review with meta-analysis
por: Hollands, Gareth J., et al.
Publicado: (2022)

Special Issue on Precision Risk Stratification-Based Screening in Colorectal Cancer
por: Stojadinovic, Alexander, et al.
Publicado: (2013)

Novel Methods for Clinical Risk Stratification in Patients with Colorectal Liver Metastases
por: Kim, Ki-Yeol, et al.
Publicado: (2015)

The health benefits and cost-effectiveness of complete healthy vending
por: Griffiths, Melda Lois, et al.
Publicado: (2020)

Benefits of patient risk stratification and targeted interventions on multidrug resistant pathogens prevention and control
por: Russo, Emanuele, et al.
Publicado: (2022)

Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children
por: Prosser, Lisa A., et al.
Publicado: (2006)

Head-to-Head Comparison of Family History of Colorectal Cancer and a Genetic Risk Score for Colorectal Cancer Risk Stratification
por: Weigl, Korbinian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vf2em9g4l8cnmuh5ovk914q7ab